Tempus AI, Inc. (NASDAQ:TEM - Get Free Report)'s stock price traded down 5.3% during mid-day trading on Tuesday . The stock traded as low as $50.50 and last traded at $51.76. 231,995 shares were traded during mid-day trading, a decline of 81% from the average session volume of 1,208,012 shares. The stock had previously closed at $54.67.
Wall Street Analyst Weigh In
Several analysts recently issued reports on the company. JPMorgan Chase & Co. lifted their target price on Tempus AI from $42.00 to $47.00 and gave the company an "overweight" rating in a research note on Wednesday, August 7th. Needham & Company LLC reissued a "buy" rating and set a $47.00 target price on shares of Tempus AI in a research note on Wednesday, August 7th. Piper Sandler started coverage on Tempus AI in a research note on Monday, August 12th. They issued a "neutral" rating and a $40.00 price objective on the stock. Morgan Stanley started coverage on Tempus AI in a research note on Tuesday, July 9th. They issued an "overweight" rating and a $44.00 price objective on the stock. Finally, Bank of America started coverage on Tempus AI in a research note on Tuesday, July 9th. They issued a "buy" rating and a $41.00 price objective on the stock. One analyst has rated the stock with a hold rating and nine have assigned a buy rating to the stock. According to MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and a consensus price target of $45.56.
Read Our Latest Stock Report on Tempus AI
Tempus AI Price Performance
The stock has a fifty day moving average price of $47.21.
Tempus AI (NASDAQ:TEM - Get Free Report) last posted its earnings results on Tuesday, August 6th. The company reported ($6.77) EPS for the quarter, missing analysts' consensus estimates of ($4.41) by ($2.36). The firm had revenue of $165.97 million during the quarter, compared to analyst estimates of $159.10 million. On average, analysts predict that Tempus AI, Inc. will post -6.51 EPS for the current year.
Institutional Investors Weigh In On Tempus AI
Institutional investors have recently modified their holdings of the company. Sandia Investment Management LP acquired a new stake in Tempus AI in the 2nd quarter valued at $136,000. Northwestern University acquired a new position in Tempus AI in the second quarter valued at approximately $491,000. Squarepoint Ops LLC acquired a new position in Tempus AI in the second quarter valued at approximately $633,000. WINTON GROUP Ltd acquired a new position in Tempus AI in the second quarter valued at approximately $634,000. Finally, Scientech Research LLC acquired a new position in Tempus AI in the second quarter valued at approximately $756,000.
Tempus AI Company Profile
(
Get Free Report)
Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.
Read More
Before you consider Tempus AI, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Tempus AI wasn't on the list.
While Tempus AI currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Click the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
